EHRA 2024: April 7-9 in Berlin, Germany and online

Discover the hottest science in the prevention and treatment of heart rhythm disorders at EHRA 2024, the scientific meeting of the European Society of Cardiology (ESC). The annual general meeting of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held online from April 7th to 9th at CityCube Berlin, Germany. Explore scientific programs.

Expect a wide range of cutting-edge scientific programs featuring groundbreaking research on new devices and technologies in atrial fibrillation, ventricular fibrillation, and sinus node disease. We also feature over 900 summaries covering new research across a range of heart rhythm disorders.

More than 120 scientific sessions will highlight the most talked about issues in the field. Sustainability considers whether remote cardiac monitoring can reduce greenhouse gas emissions, when pacemakers should be re-sterilized and re-implanted, and whether it is ethical not to reuse catheters and cardiac devices. This is the focus of two sessions. Professor Serge Boveda, Chair of the Scientific Program Committee, said: “Arrhythmia management can benefit from a number of more environmentally friendly practices, such as local manufacturing of devices to reduce transport distances, minimizing packaging and reusing catheters.” “We offer an opportunity to conserve resources while reducing our carbon footprint for the benefit of everyone’s health.” And we can treat more patients at an affordable cost. ”

Robotics is an emerging field, and experts will discuss randomized trials comparing robots and conventional ablation, as well as the use of robots to treat complex arrhythmias in congenital heart disease. Professor José Luis Merino, President of EHRA, said: ”

Artificial Intelligence (AI) Update: Multiple sessions examining the strengths and weaknesses of AI in predicting atrial fibrillation, stroke, sudden cardiac death, and personalized diagnosis and treatment.

New AI-based tools can more accurately predict who will experience arrhythmia events, remotely and virtually monitor large patient cohorts with heart rhythm disorders, and better understand arrhythmia mechanisms. It should help improve treatment. AI could also make workflows more efficient by automating some tasks and eliminating the possibility of human error. ”

Professor Andrea Sarkozy, Chair of the Scientific Program Committee

Sudden cardiac death is also on the agenda. Leaders in the field discuss how to prevent sudden cardiac arrest in young athletes, the role of genetic testing in pre-participation screening, whether non-professional athletes should also be screened, and how families cope with sudden death. Consider. “The future solution lies in improved testing and widespread use of external defibrillators in stadiums and sports halls,” Professor Boveda said. “Currently, most athletes survive cardiac arrest thanks to rapid resuscitation. Systematic investigation of blood relatives is essential to assess their risk of arrhythmia. In the future, AI may play a role in identifying recurring patterns associated with these events.”

Not to be overlooked are the difficult decisions made in cancer and arrhythmia patients. “A contemporary issue is the feasibility of anti-cancer radiotherapy for patients with implanted cardiac devices,” Professor Merino said. “Cancer patients are at increased risk of bleeding and there are concerns about using anticoagulants to treat arrhythmias, but studies show that the benefits outweigh the risks. There also needs to be more awareness about compatibility with resonance imaging (MRI). We need to provide cardiac devices so that cancer patients are not denied important tests.”

The theme of EHRA 2024 is “Innovation and education to overcome arrhythmia”. A new version of the international consensus statement on surgical and catheter ablation from EHRA and other societies is now available for the first time and will change the face of atrial fibrillation management.

The EHRA Innovation Forum will spotlight new technologies such as pacing and arrhythmia monitoring, mapping and imaging, and ablation technologies. Professor Sarkozy said: “Electrophysiologists are innovators, and the advent of AI is accelerating progress. I look forward to hearing about the tools and the latest technology.” It is a more accurate and effective arrhythmia ablation system than traditional methods. ”

The EHRA conference brings together scientists, medical professionals, and key opinion leaders involved in arrhythmia management from around the world. Register now as a press to attend EHRA2024 and receive press releases from Europe’s leading arrhythmia conferences.